Epioxa is the first and only FDA-approved epithelium-on oxygen-enriched, corneal collagen cross-linking treatment for keratoconus - a progressive eye disease that causes irreversible vision loss if untreated. Epioxa enables earlier treatment without waiting to confirm progression.